# The Advancement-Based Offing To Upscale The Next Generation Antibody Therapeutics Market Author: Pal Sinha, Barnali Author URL: https://financedigest.com/author/pal-sinha-barnali Published: 2021-11-26 Category: Research Reports Category URL: https://financedigest.com/category/research-reports Meta Title: Global Next-Gen Antibody Therapeutics Market Growth Report Meta Description: Discover the latest trends and projections for the next-generation antibody therapeutics market, with insights on biosimilar antibody products and key market URL: https://financedigest.com/the-advancement-based-offing-to-upscale-the-next-generation-antibody-therapeutics-markethtml ![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836879560-compressed.jpg) According to a new market report published by Persistence Market Research “ **Global Market Study on Next-Generation Antibody Therapeutics: Biosimilar Antibody Products to Witness Highest Growth by 2022**”, the global [**next-generation antibody therapeutics market**](http://www.persistencemarketresearch.com/market-research/next-generation-antibody-therapeutics-market.asp) is project to be valued at **US$ 2,250.0 Mn** by the end of 2015 and is expected to expand at a **CAGR of 13.0%** from 2015 to 2022, to account for **US$ 6,761.1 Mn** by 2022. Next-generation antibody therapeutics refers to improved antibody therapeutics with enhanced efficiency, greater safety, and improved delivery. Advancements in monoclonal antibody technologies have led to the development of next-generation therapeutic antibodies with reduced functional size, greater bifunctional properties, and low immunogenicity. Next-generation antibody-based therapeutics enhances existing properties of therapeutic antibodies for the treatment of various medical conditions such as cancer, [infectious diseases](https://www.financedigest.com/the-infectious-diseases-diagnostics-market-to-ride-on-procedure-simulations.html "The Infectious Diseases Diagnostics Market to ride on procedure simulations"), and autoimmune diseases. **Get Sample Copy of this Report@** [**https://www.persistencemarketresearch.com/samples/3713**](https://www.persistencemarketresearch.com/samples/3713) **Some of the major [players in the](https://www.financedigest.com/barge-transportation-market-recent-industry-developments-and-growth-strategies-adopted-by-players.html "Barge Transportation Market: Recent Industry Developments and Growth Strategies Adopted by Players") market:** - F. Hoffmann-La Roche Ltd. - Kyowa Hakko Kirin Co., Ltd. - Seattle Genetics, Inc. - ImmunoGen, Inc. - Amgen, Inc. - Biogen. - Bayer AG. - Xencor, Inc. **Request for Methodology@** [**https://www.persistencemarketresearch.com/methodology/3713**](https://www.persistencemarketresearch.com/methodology/3713) Globally, the next-generation antibody therapeutics [market is witnessing](https://www.financedigest.com/the-underwear-market-to-witness-calculated-innovation.html "The Underwear Market To Witness Calculated Innovation") significant growth due to technological advancements in antibody therapeutics and increasing the prevalence of chronic diseases. In addition, rising healthcare expenditure and growing R & D activities are driving the growth of the next-generation antibody [therapeutics market](https://www.financedigest.com/therapeutic-robots-market-2022-scope-of-current-and-future-industry-2029.html "Therapeutic Robots Market 2022 | Scope of Current and Future Industry 2029"). However, stringent regulatory requirements and long approval time for new drug restrains the [growth of the market](https://www.financedigest.com/the-next-upcoming-years-to-see-a-marked-growth-of-buttermilk-powder-market.html "The Next Upcoming Years To See A Marked Growth Of Buttermilk Powder Market"). Similarly, high costs of next-generation antibody [therapeutics is a major concern for the market](https://www.financedigest.com/innovation-based-sanity-to-maintain-the-momentum-of-dermatophytic-onychomycosis-therapeutics-market.html "Innovation-Based Sanity To Maintain The Momentum Of Dermatophytic Onychomycosis Therapeutics Market"). [North America](https://www.financedigest.com/the-north-america-synthetic-opioids-market-is-all-set-to-be-in-the-driver.html "The North America Synthetic Opioids Market is all set to be in the driver") is the largest [market for next-generation antibody therapeutics](https://www.financedigest.com/peptide-therapeutics-market-to-reach-us49-5-billion-by-2027-at-7-9-cagr-says-transparency-market-research.html "Peptide Therapeutics Market to Reach US.5 Billion by 2027 at 7.9% CAGR, Says Transparency Market Research"). This is mainly due to increasing [prevalence of chronic](https://www.financedigest.com/unstoppable-prevalence-of-infectious-and-chronic-illnesses-to-fuel-the-demand-for-diagnostics.html "Unstoppable prevalence of Infectious and Chronic Illnesses to fuel the Demand for Diagnostics") diseases and increasing healthcare spending in the region. The North America next-generation antibody therapeutics [market is projected to be valued at US$ 1,104.4 Mn by the end of 2015 and is expected to account for US$ 3,691.8 Mn by 2022 at a CAGR](https://www.financedigest.com/rapid-expansion-projected-for-ghs-labels-market-during-2022-2030-at-a-cagr-of-4-8.html "Rapid Expansion Projected for GHS Labels Market during (2022- 2030) at a CAGR of 4.8%") of 14.5%. On the basis of technology, biosimilar antibody [products are the fastest growing](https://www.financedigest.com/the-microalgae-based-product-market-to-grow-based-on-instilled-innovation.html "The Microalgae Based Product Market To Grow Based On Instilled Innovation") segment. On the basis of therapeutic application, oncology is the largest segment in next-generation antibody [therapeutics market](https://www.financedigest.com/digitized-exclusivity-to-be-the-epicenter-of-primary-peritoneal-cancer-therapeutics-market.html "Digitized Exclusivity to be the epicenter of Primary Peritoneal Cancer Therapeutics Market"). **Access Full Report@** [**https://www.persistencemarketresearch.com/checkout/3713**](https://www.persistencemarketresearch.com/checkout/3713) **The next-generation antibody [therapeutics market](https://www.financedigest.com/the-addisons-disease-therapeutics-market-to-be-thematically-digital.html "The Addisons Disease Therapeutics Market to be thematically digital") is segmented as follows:** **By Technology** - Antibody-Drug Conjugates (ADCs) - Bispecific Antibodies (BsAbs) - Fc Engineered Antibodies - Antibody Fragments and Antibody-like Proteins - Biosimilar Antibody Products **By Therapeutic Application** - Oncology - Autoimmune/Inflammatory Diseases **By Geography** - North America - Europe - Asia - Rest of the World (RoW) **[Related](https://www.financedigest.com/aonponemon-report-almost-four-times-more-budget-is-being-spent-on-property-related-risks-vs-cyber-risk.html "Aon/Ponemon report: Almost four times more budget is being spent on property related risks vs. cyber risk") Reports:** [**Crohns Disease Treatment Market**](https://www.persistencemarketresearch.com/market-research/crohns-disease-treatment-market.asp) [**Schizophrenia Treatment Market**](https://www.persistencemarketresearch.com/market-research/schizophrenia-treatment-market.asp) **About Us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp) **Contact Us:** **[Persistence Market](https://www.financedigest.com/persistence-innovation-to-replenish-the-novel-sweeteners-market.html "Persistence Innovation To Replenish The Novel Sweeteners Market") Research** Address – 305 Broadway, 7th Floor, New [York City](https://www.financedigest.com/drorfutter-joins-rimon-as-partner-in-its-new-jersey-and-new-york-city-offices.html "DrorFutter, joins Rimon as Partner in its New Jersey and New York City offices"), NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 **Japan Office:** 1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013, Japan Call 1-888-863-3700 **Sales** – sales@persistencemarketresearch.com **Website** – [https://www.persistencemarketresearch.com](https://www.persistencemarketresearch.com/) --- This blog is powered by Superblog. Visit https://superblog.ai to know more. ---